19th Dec 2007 18:30
GlaxoSmithKline PLC19 December 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons Following a revaluation of the cash element of the investment held within the USRetirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinaryshare ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and Dr RG Greig on 17 December 2007 of an increase in the notional allocation ofOrdinary share ADRs on 14 December 2007 at a price of $53.00 per ADR share:- No. of ADRsDr R G Greig 2 This notification relates to a transaction notified in accordance withDisclosure and Transparency Rule 3.1.4R(1)(a). Additionally, following the recalculation of the cash element of the notionalinvestment in GSK Ordinary share ADRs under The Plan, the previous increases inthe notional allocations of ADRs at a price of $51.25 per ADR share, announcedon 2 November 2007, are restated as follows:- No. of ADRs Previous Restated valuation valuationMr W Louv 6 7Dr M Slaoui 1 2Mr D Stout 37 38Dr D Pulman 15 16Dr R G Greig 89 88 Following a separate recalculation of the cash element of the notionalinvestment in GSK Ordinary share ADRs under The Plan, the increase in thenotional allocation of ADRs to Dr R G Greig announced on 28 November 2007 was3,279 ADRs at a price of $50.19 per ADR share (not 3,287 ADRs as previouslyannounced). This final restatement is required as a result of a technicalcalculation of notional ADRs advised to the Company by a third party. S M BicknellCompany Secretary19 December 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline